YTD sales look like BIOME will beat analysis forecasts so still looks cheap at current price based on a discounted cash flow basis. Hard to find companies delivering this sort of growth during such difficult trading conditions. I remain very positive on the upside for BIO.
YTD sales look like BIOME will beat analysis forecasts so still...
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $142.1M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | 72.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 64.0¢ | 2500 | 1 |
View Market Depth
| Last trade - 09.34am 16/07/2024 (20 minute delay) ? |
| BIO (ASX) Chart |
Day chart unavailable